Chemotherapy in Medical Technology
Navigation Links
Chemotherapy in Medical Technology
Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
... pose risks for the patient. For example, chemotherapy for retinoblastoma, a cancer affecting one in ... a therapeutic concentration in the retina. The chemotherapy destroys the bone marrow and depresses the ... close to the brain. "When we administer chemotherapy to an infant for retinoblastoma at The Vision ...... confirm previous findings when oxaliplatin-based chemotherapy and an anti-EGFR antibody are combined. ... affected when Vectibix was added to a standard chemotherapy regimen. We believe Vectibix should not be used ... R andomized trial I n combination with chemotherapy for M etastatic colorectal cancer to determine ...
... chemical entity. When bound to the polymer, the chemotherapy is rendered inactive, potentially sparing normal ... exposure to high levels of unbound, active chemotherapy and its associated toxicities. Blood vessels in ... bed allowing significantly more of the dose of chemotherapy to localize in the tumor than with standard ...
British Woman Celebrates a Year of Living Cancer-Free
... two years of traditional treatments, including chemotherapy and a bone marrow transplant, failed to keep her ... target and fight any leukemia cells that survive chemotherapy if they are activated to fight the cancer. In ... Ms. Scott underwent three to four sessions of chemotherapy -- she can't remember the exact number and ...... of picoplatin, a new generation platinum-based chemotherapy agent and the Company's lead product candidate. ... Picoplatin is a new generation platinum-based chemotherapy agent that is in clinical development for ... to overcome platinum resistance associated with chemotherapy in solid tumors. Study data to date suggest that ...
... sets this agent apart from other currently used chemotherapy agents. CTI acquired worldwide rights to ... marine product approved in Europe. Unlike other chemotherapy agents, including trabectedin, the NCI research ... where high glutathione levels are associated with chemotherapy resistance." About Brostallicin ...
... significantly enhances the anti-tumor effects of chemotherapy and has shown promising safety and efficacy ... HER2- non-overexpressing. They will receive the chemotherapy combination of gemcitabine/carboplatin with or ... metastatic breast cancer with zero to two prior chemotherapy regimens for metastatic disease; ...
... St. Jude study shows personalized chemotherapy can improve cure rate and avoid the use of ... treated using a carefully personalized chemotherapy regimen without cranial radiation, investigators ... in all patients with the use of highly effective chemotherapy regimens. The findings appear in the June 25, ...
... the follow-up period of patients that received chemotherapy on the control arm. Including the treatment and ... compared to the patients who received standard chemotherapy (CR/CRu rate=24% (17 of 70 patients) for ... p=0.009). No patient in the standard chemotherapy arm achieved a confirmed complete remission at ...
Alfacell Provides Shareholder Update
... UMM patients that have failed at least one prior chemotherapy regimen prior to submitting an NDA. Considering ... for those individuals previously treated with chemotherapy who received the combination of Onconase and ... to molecular mechanisms of inherent or acquired chemotherapy resistance. It is known that there are ...Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
... when given in sequence with standard induction chemotherapy compared to those treated with standard induction chemotherapy alone. An analysis of the study showed that ... compared to those who received induction chemotherapy alone. "We are disappointed that this study ...... studies in which pixantrone was added to standard chemotherapy regimens for treating relapsed aggressive and ... Pixantrone, when added to standard multi-agent chemotherapy regimens produced encouragingly high rates of ... it from the anthracyclines and other related chemotherapy agents. Anthracyclines are the cornerstone ...
... - Positive Initial Data across Indications and chemotherapy Regimens Suggests Bavituximab Could Have Broad ... assessing the combination of bavituximab and chemotherapy in three separate cancer trials. Bavituximab is ... is currently being tested in combination with chemotherapy in one Phase II trial in advanced lung cancer and ...
... and full-course radiotherapy. Concurrent chemotherapy with 50.5 Gy of radiation is the standard ... esophageal cancer. Although the addition of chemotherapy to radiation is beneficial, the cure rate for ... a regimen of cisplatin, and fluorouracil (5-FU) chemotherapy with concurrent radiation, a regimen associated ...
... than Complete Remissions Achieved with Standard chemotherapy ORLANDO, June 2 /PRNewswire-FirstCall/ -- ... four patients who achieved a CRu with standard chemotherapy (7 months vs. 3.5 months, p=0.03, HR=0.279; a ... (CRu) compared to patients treated with standard chemotherapy (14 out of 70 patients (20.0%) for the pixantrone ...
... discovered that when they utilized oral chemotherapy agent capecitabine, also known by its ... - approximately four to one as compared to women. chemotherapy for HNSCC is typically rigorous and even then, 40 ... The exploration of low-dose, long-term oral chemotherapy agents in adjuvant (i.e. follow-up) cancer ...
... show evidence of clinical benefits when added to chemotherapy in a Phase III study in second line advanced ... studies showed that the addition of vandetanib to chemotherapy significantly improved objective response rate, ... the studies also showed that adding vandetanib to chemotherapy resulted in a significantly longer time to ...
... - Phase 3 study has demonstrated that Induction chemotherapy prior to ChemoRadiotherapy significantly ... Group (TTCC) announced today that Induction chemotherapy (IC) delivered prior to standard ... "This trial showed that adding Induction chemotherapy to ChemoRadiotherapy increased failure-free ...
... and IL2 as immunotherapy following dose intensive chemotherapy for high-risk neuroblastoma: Children's Oncology ... approved in the U.S. for use following induction chemotherapy in older adults (older than 55) with acute ... resulting in early death following induction chemotherapy in older adults with AML. Important Safety ...
... was not looking forward to the multiple rounds of chemotherapy that he originally recommended," said Mike ... oncologist, I felt confident that I could avoid chemotherapy and its side effects without increasing the risk ... its ability to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage ...
... candidate, is a new generation platinum-based chemotherapy agent. Clinical studies to date suggest that ... to overcome platinum resistance associated with chemotherapy in solid tumors. Study data to date suggest that ... than is commonly observed with other platinum chemotherapy drugs. Picoplatin has demonstrated anti-tumor ...
... been through standard first-line or second-line chemotherapy and then received treatment with an EGFR TKI. The ... cancer who responded to at least second-line chemotherapy will be presented at ASCO in Orlando. The study ... 1120 in combination with standard second-line chemotherapy treatments for patients with advanced NSCLC. ...
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
... have failed prior platinum-containing first-line chemotherapy regiments or who have progressed within six ... to overcome platinum resistance associated with chemotherapy in solid tumors. Study data to date suggest that ... than is commonly observed with other platinum chemotherapy drugs. Picoplatin has demonstrated anti-tumor ...Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
... with Non-Hodgkins lymphomas. Following chemotherapy or radiation treatment, some patients' tumors may ... RAD51. In response to treatment with DNA-damaging chemotherapy or radiation, tumors will often turn on DNA ... repair its damaged DNA, sensitizing the tumor to chemotherapy and radiation. PCYC has patented the predictive ...... have failed prior platinum-containing first-line chemotherapy or who have progressed within six months of ... This would be a new use for a platinum chemotherapy agent. We are also continuing to analyze ... to overcome platinum resistance associated with chemotherapy in solid tumors. Study data to date indicate that ...
... of therapy, compared to 4 cycles among standard chemotherapy recipients, (1.9 months vs. 3.6 months, ... compared to patients treated with standard chemotherapy (14/70 (20.0%) for pixantrone arm compared to 4/70 (5.7%) for the standard chemotherapy arm, p = 0.02). No patient (0%) in ...
... compared to patients treated with standard chemotherapy (14/70 (20.0%) for pixantrone arm compared to 4/70 (5.7%) for the standard chemotherapy arm, p = 0.02). No patient (0%) in the standard chemotherapy arm achieved a confirmed complete remission ...
... (CRu) compared to patients treated with standard chemotherapy (14/70 (20.0%) for pixantrone arm compared to 4/70 (5.7%) for the standard chemotherapy arm, p = 0.02) with no patients in the standard chemotherapy arm achieving a confirmed complete ...
St. Jude Finds More Than 100 Gene Variations Linked With Response to Leukemia Treatment
... linked to treatment failure and the fate of chemotherapy drugs in the body for children with acute ... to use as guideposts for designing more effective chemotherapy for this cancer. The findings are ... investigations of gene variations linked to chemotherapy outcome because those studies focused only on the ...... compared to patients treated with standard chemotherapy (14/70 (20.0%) for pixantrone arm compared to 4/70 (5.7%) for the standard chemotherapy arm, p = 0.02). No patient (0%) in the standard chemotherapy arm achieved a confirmed complete remission ...
Chemoembolization Improving as Liver Cancer Treatment
... of treatment, including TACE. Because the chemotherapy is delivered directly to the tumor - rather than to the entire body as is the case with traditional chemotherapy - side effects usually are lessened. On ... chemoembolization." Embolization without chemotherapy Researchers at the European Institute of ...... survival, and the addition of Avastin to chemotherapy (FOLFOX-4 and XELOX) significantly improved ... survival by investigator assessment compared to chemotherapy alone. Furthermore, results from a separate ... and 2) whether the addition of Avastin to chemotherapy improved results compared ...
Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
... to determine the prospects of withholding chemotherapy and/or trastuzumab in HER2+, MammaPrint(R) low ... Several authoritative studies have shown that chemotherapy particularly reduces early metastasis risk. In ... clear rationale to assess the benefit of adjuvant chemotherapy in addition to other clinical information and ...Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
... ability to predict response to neoadjuvant chemotherapy in breast cancer. Dr. Laura van 't Veer, ... determine high risk patient responsiveness to chemotherapy both confirm and speak to the confidence ... setting support MammaPrint's predictive power for chemotherapy response, in addition to its previously ...... a combination of Herceptin and standard chemotherapy prior to surgery had a significantly greater ... to women who were receiving pre- operative chemotherapy alone. - Xeloda in early breast cancer: ... in Finland and Sweden indicate that the chemotherapy pill Xeloda, which is already proven in ...
... an answer to increased selection for adjuvant chemotherapy in breast cancer." Presenter: Michael Knauer, ... Several authoritative studies have shown that chemotherapy particularly reduces early metastasis risk. In ... clear rationale to assess the benefit of adjuvant chemotherapy in addition to other clinical information and ...
... blood clots in patients with cancer undergoing chemotherapy will be presented in a press conference on ... well known that patients with cancer who receive chemotherapy are at high risk for developing deadly blood ... started on the first day of the current cycle of chemotherapy and was maintained for the overall duration ...
... therapy (16 percent), or combination chemotherapy treatments (18 percent). The primary endpoint of ... trials, which included 10,441 patients, used chemotherapy as the anticancer regimen. The primary ... benefits for the individual patient when treating chemotherapy -- induced anemia. American Society of ...
... proportion of anemic cancer patients who were on chemotherapy and who received ESAs needed blood transfusions ... changes in anemic Medicare patients receiving chemotherapy treated with ESAs before and after implementation ... utilization in anemic Medicare patients receiving chemotherapy and treated with ESAs after implementation of the ...
... platelet transfusion approach following high-dose chemotherapy and autologous stem cell transplantation. ... cause of thrombocytopenia: those who had received chemotherapy for a hematologic malignancy (313 patients), chemotherapy for a solid tumor (seven patients), autologous ...
Other ContentscatabolismcatabolismcecumcecumwallwallwallwallwallwallwallwallwallmediatedmediatedmediatedmediatedmediatedmediatedmediatedmediatedmediatedcenterscenterscenterscenterscenterscenterscenterscentersOther TagscoastparkparkparkparkparkeacheacheacheacheachboxespregnanciessafelyOther Tagscardiologist 2cardiologist 3cardiologist 4cardiologist 5cardiologist 6marketed 2diagnostic 2diagnostic 3diagnostic 4diagnostic 5diagnostic 6diagnostic 7diagnostic 8diagnostic 9home 2home 3home 4home 5home 6home 7home 8home 9consumers 2consumers 3
(Date:11/30/2009)...stration rates and register online now for the pre....iofwco-ecceo10.org/ , WHAT: IOF WCO-ECCEO10 i...is Foundation (IOF) and the European Society for C...steoarthritis (ESCEO). More than 5,000 participant...e exciting scientific programme includes 12 plenar...
(Date:11/30/2009)...December 2009 print issue of The FASEB Journal c... their fertility that women have had since the 196...here androgenic hormones work in the testis to con...his opens a promising avenue for the development o...pe to those who cannot have children because of lo...
(Date:11/26/2009)...,s most distinctive residents. ,Everyone wants to ... says Michelle McComb from Florida Atlantic Univer...Perhaps their visual field has been enhanced by th...rks excellent stereovision and depth perception. H...s of thought on this theory. In 1942, G. Walls spe...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2IRIDEX Announces Second Quarter 2009 Conference Call and Release Date 53886 1Rooks Show Intelligence in Catching the Worm 53884 1Rooks Show Intelligence in Catching the Worm 53884 2Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions 53882 1Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions 53882 2Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions 53882 3(Date:12/1/2009)...ORLEANS, Dec. 1 The Ame...gest professional association of blood specialists...SH Annual Meeting from December 5-8, 2009, at the ... LA. The meeting will showcase the latest research... my pleasure to host ASH,s 51st annual meeting, wh...
(Date:12/1/2009)...ELD, Mich., Dec. 1 Firs...First Mercury" or the "Company") announced today t...clared a quarterly cash dividend of $0.025 per sha...f record at the close of business on December 15, ...ration ,, First Mercury Financial Corporation ...
(Date:12/1/2009)...ination because pandemic,s course remains unpredic...s) -- A U.S. health official said Tuesday that H1N...tionally, but many experts agreed the virus could ... now widespread in 32 states -- down from 43 state... of the U.S. Centers for Disease Control and Preve...
(Date:12/1/2009)...ARCH TRIANGLE PARK, N.C., Dec. 1 M... and have expanded over the years serving the top ...ty which was originally set up in an area of 2000 ..., as part of the suite of services by Max Neeman, ...valuable offering. ,, The pharmacy inventory ma...
(Date:12/1/2009)...ON, Dec. 1 The followin...tional Development: ,, Chairman Kerry, Ranking ...I am honored to be nominated by President Obama to...y for International Development, and I appreciate ...cretary of State Clinton has expressed the convict...
Breaking Medicine News(10 mins):Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9[1] 51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care[0] First Mercury Financial Corporation Declares Dividend[0] Swine Flu Waning, But Could Return [0] Max Neeman International Expands Its Pharmacy Services Facility In Delhi[0] Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |